Search Results - BryanD Choi

Refine Results
  1. 1
    CAR-T cell therapy for the treatment of adult high-grade gliomas

    CAR-T cell therapy for the treatment of adult high-grade gliomas by Sangwoo Park, Marcela V. Maus, Bryan D. Choi

    Published 2024
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Immunotherapy for Glioblastoma: Adoptive T-cell Strategies

    Immunotherapy for Glioblastoma: Adoptive T-cell Strategies by Bryan D. Choi, Marcela V. Maus, Carl H. June, John H. Sampson

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Immunotherapy for malignant glioma

    Immunotherapy for malignant glioma by CarterM Suryadevara, Luis Sánchez-Pérez, John H. Sampson, Terence Verla, ElizabethA Reap, BryanD Choi, Peter E. Fecci

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma

    Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma by Bryan D. Choi, Carter M. Suryadevara, Patrick C. Gedeon, James E. Herndon, Luis Sánchez-Pérez, Darell D. Bigner, John H. Sampson

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    EGFRvIII‐Targeted Vaccination Therapy of Malignant Glioma

    EGFRvIII‐Targeted Vaccination Therapy of Malignant Glioma by Bryan D. Choi, Gary E. Archer, Duane A. Mitchell, Amy B. Heimberger, Roger E. McLendon, Darell D. Bigner, John H. Sampson

    Published 2009
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Are BiTEs the “missing link” in cancer therapy?

    Are BiTEs the “missing link” in cancer therapy? by Carter M. Suryadevara, Patrick C. Gedeon, Luis Sánchez-Pérez, Terence Verla, Christopher Alvarez‐Breckenridge, Bryan D. Choi, Peter E. Fecci, John H. Sampson

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Human Regulatory T Cells Kill Tumor Cells through Granzyme-Dependent Cytotoxicity upon Retargeting with a Bispecific Antibody

    Human Regulatory T Cells Kill Tumor Cells through Granzyme-Dependent Cytotoxicity upon Retargeting with a Bispecific Antibody by Bryan D. Choi, Patrick C. Gedeon, James E. Herndon, Gary E. Archer, Elizabeth A. Reap, Luis Sánchez-Pérez, Duane A. Mitchell, Darell D. Bigner, John H. Sampson

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma

    Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma by Bryan D. Choi, Elizabeth R. Gerstner, Matthew J. Frigault, Mark B. Leick, Christopher Mount, Leonora Balaj, Sarah Nikiforow, Bob S. Carter, William T. Curry, Kathleen Gallagher, Marcela V. Maus

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma

    Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma by Bryan D. Choi, Chien‐Tsun Kuan, Mingqing Cai, Gary E. Archer, Duane A. Mitchell, Patrick C. Gedeon, Luis Sánchez-Pérez, Ira Pastan, Darell D. Bigner, John H. Sampson

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Challenges in Global Access to CAR-T cells: an Asian Perspective

    Challenges in Global Access to CAR-T cells: an Asian Perspective by William Ying Khee Hwang, Satoshi Takahashi, Bryan D. Choi, He Huang, Shin Kawamata, Soo Chin Ng, Pawan Kumar Gupta, Amir Ali Hamidieh, Chaiyong Koaykul, Cospiahadi Irawan, Alok Srivastava

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Chimeric antigen receptor costimulation domains modulate human regulatory T cell function

    Chimeric antigen receptor costimulation domains modulate human regulatory T cell function by Angela C. Boroughs, Rebecca C. Larson, Bryan D. Choi, Amanda A. Bouffard, Lauren S. Riley, Erik B. Schiferle, Anupriya S. Kulkarni, Curtis L. Cetrulo, David T. Ting, Bruce R. Blazar, Shadmehr Demehri, Marcela V. Maus

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Myeloablative Temozolomide Enhances CD8+ T-Cell Responses to Vaccine and Is Required for Efficacy against Brain Tumors in Mice

    Myeloablative Temozolomide Enhances CD8+ T-Cell Responses to Vaccine and Is Required for Efficacy against Brain Tumors in Mice by Luis Sánchez-Pérez, Bryan D. Choi, Gary E. Archer, Xiuyu Cui, Catherine Flores, Laura A. Johnson, Robert J. Schmittling, David J. Snyder, James E. Herndon, Darell D. Bigner, Duane A. Mitchell, John H. Sampson

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma

    Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma by Matthew J. Frigault, Jörg Dietrich, Maria Martinez‐Lage, Mark B. Leick, Bryan D. Choi, Zachariah DeFilipp, Yi‐Bin Chen, Jeremy S. Abramson, Jennifer L. Crombie, Philippe Armand, Lakshmi Nayak, Chris Panzini, Lauren S. Riley, Kathleen Gallagher, Marcela V. Maus

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    EGFRvIII-Specific Chimeric Antigen Receptor T Cells Migrate to and Kill Tumor Deposits Infiltrating the Brain Parenchyma in an Invasive Xenograft Model of Glioblastoma

    EGFRvIII-Specific Chimeric Antigen Receptor T Cells Migrate to and Kill Tumor Deposits Infiltrating the Brain Parenchyma in an Invasive Xenograft Model of Glioblastoma by Hongsheng Miao, Bryan D. Choi, Carter M. Suryadevara, Luis Sánchez-Pérez, Shicheng Yang, Gabriel De Leon, Elias Sayour, Roger E. McLendon, James E. Herndon, Patrick Healy, Gary E. Archer, Darell D. Bigner, Laura A. Johnson, John H. Sampson

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia

    Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia by Mark B. Leick, Harrison Silva, Irene Scarfò, Rebecca C. Larson, Bryan D. Choi, Amanda A. Bouffard, Kathleen Gallagher, Andrea Schmidts, Stefanie R. Bailey, Michael C. Kann, Max Jan, Marc Wehrli, Korneel Grauwet, Nora Horick, Matthew J. Frigault, Marcela V. Maus

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts

    Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts by Carter M. Suryadevara, Rupen Desai, S. Harrison Farber, Bryan D. Choi, Adam M. Swartz, Steven H. Shen, Patrick C. Gedeon, David J. Snyder, James E. Herndon, Patrick Healy, Elizabeth A. Reap, Gary E. Archer, Peter E. Fecci, John H. Sampson, Luis Sánchez-Pérez

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss

    EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss by John H. Sampson, Bryan D. Choi, Luis Sánchez-Pérez, Carter M. Suryadevara, David J. Snyder, Catherine Flores, Robert J. Schmittling, Smita K. Nair, Elizabeth A. Reap, Pamela K. Norberg, James E. Herndon, Chien-Tsun Kuan, Richard A. Morgan, Steven A. Rosenberg, Laura A. Johnson

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma

    CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma by Bryan D. Choi, Xiaoling Yu, Ana P. Castaño, Henia Darr, Daniel B. Henderson, Amanda A. Bouffard, Rebecca C. Larson, Irene Scarfò, Stefanie R. Bailey, Genevieve M. Gerhard, Matthew J. Frigault, Mark B. Leick, Andrea Schmidts, Jason Sagert, William T. Curry, Bob S. Carter, Marcela V. Maus

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment

    Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment by Youmna Kfoury, Ninib Baryawno, Nicolas Sévère, Shenglin Mei, Karin Gustafsson, Taghreed Hirz, Thomas Brouse, Elizabeth W. Scadden, Anna A. Igolkina, Konstantinos D. Kokkaliaris, Bryan D. Choi, Nikolas Barkas, Mark A. Randolph, John H. Shin, Philip J. Saylor, David T. Scadden, David B. Sykes, Peter V. Kharchenko

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma

    Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma by Carter M. Suryadevara, Rupen Desai, Melissa L. Abel, Katherine A. Riccione, Kristen A. Batich, Steven H. Shen, Pakawat Chongsathidkiet, Patrick C. Gedeon, Aladine A. Elsamadicy, David J. Snyder, James E. Herndon, Patrick Healy, Gary E. Archer, Bryan D. Choi, Peter E. Fecci, John H. Sampson, Luis Sánchez-Pérez

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: